Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.07 USD | +1.69% | +5.46% | -9.69% |
Apr. 26 | ResMed tops quarterly profit estimates on strong demand for sleep apnea devices | RE |
Apr. 23 | PHILIPS NV : Jefferies reiterates its Sell rating | ZD |
Sales 2024 * | 18.8B 20.1B | Sales 2025 * | 19.73B 21.1B | Capitalization | 17.9B 19.14B |
---|---|---|---|---|---|
Net income 2024 * | 702M 751M | Net income 2025 * | 1.12B 1.19B | EV / Sales 2024 * | 1.23 x |
Net Debt 2024 * | 5.27B 5.63B | Net Debt 2025 * | 4.3B 4.6B | EV / Sales 2025 * | 1.12 x |
P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
17.4
x | Employees | 69,656 |
Yield 2024 * |
4.48% | Yield 2025 * |
4.66% | Free-Float | 99.16% |
Latest transcript on Philips NV
1 day | +1.69% | ||
1 week | +5.46% | ||
Current month | +5.35% | ||
1 month | +5.14% | ||
3 months | -7.43% | ||
6 months | +15.64% | ||
Current year | -9.69% |
Managers | Title | Age | Since |
---|---|---|---|
Roy Jakobs
CEO | Chief Executive Officer | 50 | 09-12-31 |
Director of Finance/CFO | 62 | 86-12-31 | |
Shez Partovi
CTO | Chief Tech/Sci/R&D Officer | 57 | 21-03-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Pyott
BRD | Director/Board Member | 70 | 14-12-31 |
Sanjay Poonen
BRD | Director/Board Member | 55 | 21-12-31 |
Director/Board Member | 68 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 21.07 | +1.69% | 924,186 |
24-04-25 | 20.72 | -1.19% | 600,494 |
24-04-24 | 20.97 | -0.19% | 654,484 |
24-04-23 | 21.01 | +1.94% | 1,953,024 |
24-04-22 | 20.61 | +3.15% | 1,559,045 |
Delayed Quote Nyse, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- PHIA Stock
- PHG Stock